Clinical Trial

Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation

Study acronym: CAREFUL-CA
Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter, prospective, observational diagnostic accuracy study enrolls patients undergoing thrombectomy with intraoperative cerebral autoregulation monitoring and follows them up at predefined time points up to 90 days post-enrollment. The study aims to determine whether impaired cerebral autoregulation during thrombectomy can serve as an ultra-early biomarker for predicting futile recanalization in patients with acute ischemic stroke.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-05-07
critical Primary endpoint(s) modified 2026-05-07
Trial Details
NCT Number NCT07556068
Lead Sponsor Beijing Shijitan Hospital, Capital Medical University
Conditions Acute Ischemic Stroke, Cerebral Autoregulation
Enrollment 129 participants
Start Date 2026-04-20
Primary Completion 2026-10-15 (estimated)
Study Completion 2026-10-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-06